Outcomes of TAMIS-Total Mesorectal Excision Versus Transanal Loco-regional Excision for T2 Low Rectal Cancer

Osama Mohammad Ali ElDamshety50 enrolled

Overview

Cases with stage T2 N0 low rectal cancer will undergo either Transanal minimally invasive total mesorectal excision or transanal minimally invasive locoregional resection.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Low Rectal Cancer

Interventions

Transanal minimally invasive total mesorectal excisionPROCEDURE

transanal minimally invasive locoregional resectionPROCEDURE

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * T2 N0 low rectal cancer Exclusion Criteria: * patients unfit for laparoscopic resection * Unwilling to share in the study

Outcomes

Primary Outcomes

Overall percent of postoperative complications.

the over all percentage of Postoperative complications concerning Pelvis abscess, anastomosis disruption, bleeding, Fistula and continence function.

Time frame: 30 days

Secondary Outcomes

Hospital stay

Number of Days starting from the admission till discharge

Time frame: 30 days

Recurrence.

number of local and distant recurrence

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.